Non-classic unexpected functions of vitamin D

Pediatric Endocrinology Reviews

Volumn 8, Issue 2, 2010, Pages 103-107

  Weisman, Yosef ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Vitamin D; Vitamin D and cancer; Vitamin D and cardiovascular diseases; Vitamin D and immunity

Indexed keywords

1,25 DIHYDROXYERGOCALCIFEROL; 25 HYDROXYVITAMIN D; 25 HYDROXYVITAMIN DEXTRO 1ALPHA HYDROXYLASE; COLECALCIFEROL; CYTOCHROME P450; CYTOCHROME P450 27B1; ERGOCALCIFEROL; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D RECEPTOR;

ADAPTIVE IMMUNITY; ANTIBACTERIAL ACTIVITY; APOPTOSIS; AUTOIMMUNE DISEASE; BONE METABOLISM; BREAST CANCER; CALCIUM METABOLISM; CANCER MORTALITY; CANCER RISK; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHOLESTEROL METABOLISM; COLORECTAL CANCER; DIABETES MELLITUS; DISEASE COURSE; DRUG EFFECT; DRUG MECHANISM; GLUCOSE METABOLISM; HUMAN; HYPERCALCEMIA; INNATE IMMUNITY; INSULIN RESISTANCE; MULTIPLE SCLEROSIS; NEOPLASM; NONHUMAN; OUTCOME ASSESSMENT; PATHOGENESIS; PROSTATE CANCER; PROTEIN EXPRESSION; REVIEW; RISK FACTOR; SARCOIDOSIS; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

CARDIOVASCULAR DISEASES; HUMANS; NEOPLASMS; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 78650362351     PISSN: 15654753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. DeLuca HF. Evolution of our understanding of Vitamin D. Nutrition Reviews 2008;66(suppl 2):573-578
2. Plum LA, DeLuca HF. The functional metabolism and molecular biology of vitamin D action. In: Holick MF, ed. Vitamin D: Physiology. Molecular biology and clinical applications, 2nd ed. Totowa, NJ: The Humana Press, 2009
3. Weisman Y, Harell A, Edelstein S, et al. 1 alpha, 25-Dihydroxyvitamin D3 in vitro synthesis by human decidua and placenta. Nature 1979;281:317-319
4. 3-1α hydroxylase in human health and disease. J Steroid Biochem Mol Biol 2007;103:316-321
5. 3 in human skin and the physiologic consequences. Science 1980;210:203-205
6. 3. Biochemistry 1968;7:3317-3322
7. Lawson DE, Fraser DR, Kodicek E, et al. Identification of 1,25-dihydroxycholeciferol, a new kidney hormone controlling calcium metabolism. Nature 1971;230:228-230
8. nd edn. San Diego: Elsevier Academic Press, 2005;411-428
9. Hoenderop JG, Nilius B, Bindels RJ. Calcium absorption across epithelia. Physiol Rev 2005;85:373-422
10. Benn BS, Ajibade D, Porta A, et al. Active intestinal calcium transport in the absence of transient receptor potential vanilloid type 6 and calbindin-D9k. Endocrinology 2008;149:3196-3205
11. 2+ absorption between enterocytes. Mol Biol Cell 2008;19:1912-1921
12. nd ed. New York: Elsevier, 2005;1197-1205
13. Adams JS, Hewison M. Update in Vitamin D. J Clin Endocrinol Metab 2010;95:471-478
14. Barbour GL, Coburn JW, Slatopolsky E, et al. Hypercalcemia in an anephric patient with sarcoidosis: Evidence for extrarenal generation of 1,25-dihydroxy Vitamin D. N Engl J Med 1981;305:440-443 (Pubitemid 11047046)
15. nd ed. San Diego: Elsevier Academic Press, 2005;219-261
16. nd ed. San Diego: Elsevier Academic Press, 2005;167-191
17. nd ed. San Diego: Elsevier Academic Press, 2005;1207-1237
18. Weisman Y, Bab I, Gazit D, et al. Long-term intracaval calcium infusion therapy in end-organ resistance to 1,25-dihydroxyvitamin D Am J Med 1987;83: 984-990
19. Bouillon R, Biochoff-Ferrari H, Willett W Vitamin D and health: Perspectives from mice and man. J Bone Min Res 2008;23:974-979
20. Samuel S, Sitrin MD. Vitamin D's role in cell proliferation and differentiation. Nutrition Reviews 2008 ;66(Supp.2): S116-S124
21. Abe E, Miura C, Sakagami, et al. Differentiation of mouse myeloid leukemia cells induced by 1α ,25-dihydroxyvitaminD3. Proc Natl Acad Sci USA 1981;78:4990-4994 (Pubitemid 12225607)
22. Garland CF, Garland FC, Gorham ED, et al. The role of vitamin D in cancer prevention. Am J Public Health 2006;96:252-261
23. Freedman DM, Looker AC, Chang SC, Graubard BI. Prospective study of serum Vitamin D and cancer mortality in the United States. J Natl Cancer Inst 2007;99:1594-1602
24. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266-281
25. Jenab M, Bueno-de-Mesquita HB, Van Duijnhoven FJ, et al. Association between pre-diagnostic circulating Vitamin D concentration and risk of colorectal cancer in European populations: a nested case control study BMJ 2010;340:b5500.doi.10.1136/bmj.b5500
26. Almquist M, Bondeson AG, Bondeson L, et al. Serum levels of vitamin D, PTH, Calcium and breast cancer risk- a prospective nested case-control study Int J Cancer 2010; Jan 28 (Epub a head of print).
27. Yin L, Raum E, Haug U, et al. Meta-analysis of longitudinal studies: Serum vitamin D and prostate cancer risk. Cancer Epidemiol 2009;33:435-445.
28. Adams JS, Hewison M. unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunology. Nat Clin Pract Endocrinol Metab 2007; 4:80-90.
29. Adorini L, Penna G. Dendritic cell tolerogenicity: a key mechanism in immunomodulation by vitamin D receptor agonists. Hum Immunol 2009;70:345-352
30. Lemire JM, Adams JS, Sakai R, Jordan SC. 1-alpha, 25-dihydroxyvitamin D, suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J Clin Invest 1984;74:657-661
31. Ponsonby AL. Vitamin D and three autoimmune diseases - multiple sclerosis, type 1 diabetes, rheumatoid arthritis. Photo Chem Photobiol 2005;81:1267-1275
32. Munger KL, Zhang SM, O'Reilly E, et al. Vitamin D, intake and incidence of multiple sclerosis. Neurology 2004;62:60-65
33. Munger KL, Levin LI, Hollis BW et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006;296:2832-2838 (Pubitemid 44969183)
34. Zipitis CS, Akobeng AK. Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. Arch Dis Child 2008 ;93:512-517
35. Hyponen EN, Laara E, Reunanen A, et al. Intake of vitamin D and risk of type 1 diabetes: a birth cohort study. Lancet 2001;358:1500-1503
36. 3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci U S A 1996;93:7861-7864
37. 3 completely protects NOD mice from insulin-dependent diabetes mellitus. Arch Biochem Biophys 2003;417:77-80
38. Rook GA, Steelle J, Fraher L, et al. VitaminD3, gamma interferon, and control of proliferation of mycobacterium tuberculosis by human monocytes. Immunology 1986;51:159-163
39. Etzioni A, Hochberg Z, Pollak S, et al. Defective leukocyte fungicidal activity in end-organ resistance to 1,25-dihydroxyvitamin D. Pediatr Res 1989;25:276-279
40. Liu PT, Stenger S, Li H et al. Toll-like receptor triggering of vitamin D-mediated human antimicrobial response. Science 2006 ;311:1770-1773
41. Hansdottir S, Monick MM, Hinde SL, et al. Respiratory epithelial cells convert inactive vitamin D to its active form. Potential effects on host defense. J Immunol 2008;181:7090-7099
42. 3. J Invest Dermatol 2008;128:816-824
43. Adams JS, Hewison M. Update in Vitamin D. J Clin Endocrinol Metab 2010;95:471-478
44. 3 and pancreatic B cell function: Vitamin D receptors, gene expression and Insulin secretion. Endocrinology 1994 ;134:1602-1610
45. Bland R, Markovic D, Hill CE. Expression of 25-hydroxyvitamin D-1 alpha-hydroxylase in pancreatic islets. J steroid Biochem Mol Biol 2004;89-90:121-125
46. Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, diabetes and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 2004;27:2813-2818 (Pubitemid 39565042)
47. Snijder M, Van Dam R, Visser M, et al. Vitamin D and diabetes. Diabetologia 2006;49:217-218
48. Vang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008;117:503-511
49. Forman JP, Giovannucci E, Holmes MD, et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007;49:1063-69
50. Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey 2007;Am J Hypertens 20:713-719 (Pubitemid 46936167)
51. Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 2008;168:1178-1180 (Pubitemid 351831400)
52. Pilz S, Dobing H, Fischer TE, et al. Low vitamin D levels predict stroke in patients referred to coronary angiography. Stroke 2008;39:2611-2613
53. Pilz S, Marz W, Wellnitz B, et al. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J Clin Endocrinol metab 2008;93:3927-3935
54. 3 is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002;110:229-238
55. 3 modifies growth and contractile function of vascular smooth muscle of spontaneously hypertensive rats. Am J Hypertens 1989;2:553-556
56. 2 Vitamin D inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus Circulation 2009;120:687-698
57. Pittas AG, Chung M, Trikalinos T, et al. Systematic review: Vitamin D and cardiometabolic outcomes. Ann Intern Med 2010;152:307-314
58. Wang L, Manson JE, Song Y, Sesso HD. Systematic review: Vitamin D and calcium supplementation in prevention of cardiovascular events. Am Intern Med 2010;152:315-323
59. Ullah MI, Uwaifo GI, Nicholas WC, Koch CA. Does vitamin D deficiency cause hypertension? Current evidence from clinical studies and potential mechanisms. Int J Endocrinol 2010;579-640. Epub 2009 Nov 10